Chronicled, the administrator of the pharmaceutical blockchain group MediLedger announced a fourth working group to address Medicaid rebates.
In the United States, certain types of registered pharmacies get special so-called 340B Medicaid pricing from drug manufacturers. But not all drugs eligible for Medicaid are distributed by 340B registered pharmacies. For non 340B pharmacies, a rebate is claimed from the drug manufacturer. However, in some cases, both 340B pricing is provided and a Medicaid rebate is claimed, a double discount that’s strictly not allowed.
As a result, manufacturers are tightening procedures creating extra administration. It’s not a small problem. According to MediLedger 340B eligibility has grown from 1,000 pharmacies to 28,000 over the past ten years and $35 Billion in annual spend.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
